Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Posted on: Jun/18/2024 22:54:39
FDA approves $ABBVs Skyrizi for first-line ulcerative colitis:
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174621737
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.